International Clinical Trial: Combining fMRI and blood biomarker studies to investigate cognitive impairment in cerebral small vessel disease

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133530) titled 'Combining fMRI and blood biomarker studies to investigate cognitive impairment in cerebral small vessel disease' on Sept. 29.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: People's Hospital of Jianyang City

Condition: Cerebral small vessel disease

Intervention: CSVD group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-03-11

Target Sample Size: CSVD group:100;HC group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=337897

Published by HT Digital Content Services with permission ...